Previous studies have shown that miR-203 is a skin-specific microRNA (miRNA) with a profound role in skin cell differentiation. However, emerging microarray and deep sequencing data revealed that miR-203 is also expressed in embryonic skeletal muscle and myoblasts. In this study, we found that miR-203 was transiently upregulated in chicken embryos on days 10 to 16 (E10-E16) and was sharply downregulated and even not expressed after E16 in chicken embryonic skeletal muscle. Histological profiles and weight variations of embryo skeletal muscle revealed that miR-203 expression is correlated with muscle development.
Skeletal muscle development is a multistage process involving genetic regulation and environmental cue guidance. [1] [2] [3] During skeletal myogenesis, muscle precursor cells (myoblasts) differentiate from the somite, migrate to the limb buds and begin to express specific myogenic transcription factors, resulting in the differentiation of myoblasts into myotubes. [4] [5] When myoblasts initiate the differentiation process, the proliferating myoblasts pause the cell cycle, migrate and adhere to each other, and then fuse to form multinuclei myotubes. 6 In addition, this differentiation process also occurs during postnatal growth and regeneration of adult skeletal muscle, which is dependent on the activation of muscle satellite cells. 7 MEF2C belongs to the myocyte enhancer factor 2 family (MEF2) comprising four members encoded by different genes-MEF2A, B, C and D. 8 In Drosophila, mutations in MEF2 result in a complete loss of muscle differentiation, [9] [10] [11] and more than 200 target genes and over 650 regions of the genome are bound by MEF2 during myogenesis, 12 demonstrating its central role in muscle development. During mouse and chick embryogenesis, MEF2C is the first MEF2 family member to be expressed, 13 but it has no impact on myoblast specification. [10] [11] Loss-of-function mutations of MEF2C in mice result in embryonic lethality because of the cardiac malformation, 14 and skeletal muscle-specific deletion of MEF2C will cause improper sarcomere organisation and weakened M lines. 15 In addition, as a co-activator, MEF2C can interact with MAML1, Notch3 and the p38 MAPK pathway, thereby promoting skeletal muscle differentiation. [16] [17] [18] As transcription factors, many muscle-specific genes, as well as muscle-specific microRNAs (miRNAs) such as miR-1, miR-133 and miR-206, have been shown to be regulated by MEF2C. [18] [19] c-JUN, a transcriptional activator of the AP-1 family, plays positive roles in cell proliferation and cell cycle progression. A mouse bearing a c-JUN null mutation will die at mid-gestation because of the retardation of cell proliferation, and the primary fibroblasts from this c-JUN null embryo show greatly reduced growth rates in culture. 20 c-JUN gain-and-loss-of-function reveals that the positive role of c-JUN in cell cycle progression is p53 dependent. 21 p53 is an important tumour suppressor gene that has an inhibitory role in cell cycle progression through its target gene, the cyclin-dependent kinase inhibitor p21.
22 c-JUN inhibits p53 transcription by direct binding to a variant AP-1 site in the p53 promoter, thereby repressing p53 expression and inducing cell cycle progression. 21 Recently, several miRNAs, particularly miR-1, miR-206 and miR-133, were found to participate in muscle development. [23] [24] These myogenic miRNAs (myomiRs) regulate muscle development by fine-tuning gene expression or acting as binary on/off switches. 25 To better understand this regulation, we previously counted all of the verified miRNAs involved in skeletal muscle differentiation. 26 Through interactions with many myogenic regulators, these miRNAs have important roles in the regulation of skeletal muscle differentiation. However, none of these miRNAs were found in a chicken embryo study, which is a classic model for development research.
miR-203 is widely known as a tumour suppressor and skinspecific miRNA. 27 It can directly repress the expression of the 'stemness-maintaining' transcription factor p63 during epidermis stratification and differentiation, thus restricting proliferative potential, inducing cell cycle exit and finally promoting epidermal differentiation. [28] [29] In rhabdomyosarcoma cell, re-expression of miR-203 can inhibited cell growth and promoted myogenic differentiation. 30 However, none of the previous studies have noticed its expression and roles in skeletal muscle development. In C2C12 myoblasts, 23 quail myoblasts 31 and chicken skeletal muscle, 32 the expression of miR-203 can be detected by microarray, quantitative polymerase chain reaction (qPCR) or deep sequencing. In addition, our previous study found that the expression of miR-203 was highly enriched in chicken embryonic skeletal muscle. 33 Interestingly, miR-203 expression can be detected in embryonic leg muscle, but the expression was not observed in adult leg muscle. 33 In addition, miR-203 shows lower expression in fast-growing, heavy-mass chicken skeletal muscle. 32, 33 In the present study, we explored the functional significance of miR-203 in chicken skeletal muscle development and found that miR-203 could repress primary myoblast proliferation and differentiation by directly inhibiting c-JUN and MEF2C expression, respectively. Our results confirm and illustrate that a skin-specific miRNA can also express and function in skeletal muscle development.
Results miR-203 expression correlates with chicken embryonic skeletal muscle development. Our previous microarray data showed that the expression level of miR-203 is significantly higher in the leg muscle of embryonic day 14 (E14) dwarf chickens than in E14 normal chickens (Figure 1a) . 33 Surprisingly, miR-203 shows abundant detection signals at E14 in both types of chickens but is not expressed at the age of 7 weeks (7 wk; Figure 1a ). Considering that miR-203 is specifically expressed in the skin, its high expression level in embryonic leg muscle can be due to the pollution of skin tissue. To eliminate this possibility, we collected other leg muscle samples from E14 and 7 wk dwarf and normal chickens by carefully removing the skin tissue and outer muscle. Subsequently, we used DSP, which is specifically expressed in skin tissue, as an RT-PCR marker to further eliminate the pollution of skin RNA ( Supplementary  File 3) . Northern blot analysis showed that miR-203 is indeed expressed in the leg muscle of E14 chickens but is not expressed in the leg muscle of 7-wk-old chickens (Figure 1b) . Importantly, miR-203 in situ hybridisation in dwarf E14 leg muscle also confirmed its expression in muscle tissue ( Figure 1c ).
In addition, miR-203 has a significantly higher expression level in dwarf chickens than in normal chickens (Figure 1d ), a finding that is consistent with our previous microarray data. 33 Furthermore, during skeletal muscle development in dwarf chickens, miR-203 expression is upregulated from E10-E16 and sharply downregulated after E16 (Figure 1e) . The high expression level of miR-203 at E14 and E16 was also validated using Northern blot (Figure 1f ), although the low expression of miR-203 could not be detected at other stages due to the low sensitivity of the assay. In normal chickens, miR-203 is highly expressed at E12 and E14, and miR-203 expression is sharply downregulated after E18 (Supplementary File 1) . Altogether, these results confirmed that miR-203 is expressed in chicken embryonic skeletal muscle and indicated that it might have potential roles in skeletal muscle development.
Histological profiles of muscle fibres and weight variations of skeletal muscle during chicken embryonic development. Gene expression can be linked to organismal phenotypes. 34 To better understand the potential role of miR-203, we next studied the skeletal muscle phenotypes during chicken embryonic development and observed their correlation with miR-203 expression. Normal chickens have heavier E14 leg muscle weight than dwarf chickens (Figure 1g) , and haematoxylin-eosin (H-E) staining showed that the muscle fibres are clear and plump in normal chickens but blurry and flat in dwarf chickens (Figure 1h ), suggesting that leg muscle development in dwarf chickens is slower than that of normal chickens. During dwarf chicken leg muscle development, miR-203 exhibits transient upregulated expression from E10-E16 but is sharply downregulated after E16. Therefore, we studied the histological profiles and weight variations of
The expression of miR-203 on skeletal muscle cells W Luo et al these leg muscle samples. The weights of leg muscles were increased slowly from E10-E16 but were sharply increased after E16 (Figure 1i ). H-E staining showed that the structure of the muscle fibres was blurry and irregular during E10-E16, with clear and obvious fibre cross sections in E18 (Figure 1j and Supplementary File 2). Together with the miR-203 expression data, we found that higher or upregulated expression of miR-203 is accompanied by slow leg muscle development, and the low expression of miR-203 is followed by a rapid increase in muscle weight and full formation of muscle fibres. These findings suggested that miR-203 might have an inhibitory role in skeletal muscle development.
The expression of miR-203 is upregulated in proliferating myoblasts and is sharply downregulated during differentiation in vitro. To further study the potential roles of miR-203, we separated chicken primary myoblasts ( Figure 2a The expression of miR-203 on skeletal muscle cells W Luo et al miR-203 represses myoblast differentiation. As cell cycle arrest is a critical step in the myoblast differentiation process and miR-203 is likely to be implicated in myoblast differentiation, we studied the effects of miR-203 on myoblast differentiation. Primary myoblasts cultured in GM were transfected with the miR-203 mimic or control duplexes. After transfection, the GM was replaced with differentiation medium to induce myoblast differentiation. Two major myoblast differentiation marker genes, myogenin and MHC, were detected 72 h after differentiation according to qPCR and western blot analyses. However, there were no differences in the expression levels of the cells transfected with the miR-203 and those transfected with the control duplex ( Figure 4a ). Considering that the myotubes formed before DM3 are fewer in number and small in size, the differentiation status and fusion index of these cells at this stage may be too low to identify the difference between these two transfected groups. Therefore, we subsequently performed the transfection at DM2 and observed the expression of myogenin and MHC at DM5. Under this condition, the expression of myogenin was significantly downregulated, and the expression of MHC was slightly lower in the miR-203-transfected myoblasts than that in the control myoblasts ( Figure 4b ). Furthermore, we conducted transfection at DM4 and detected myogenin and MHC gene expression at DM7. Myogenin and MHC were both significantly downregulated in the miR-203-transfected myoblasts compared with the control myoblasts (Figure 4c ). Myoblast fusion is a critical process during muscle differentiation. Therefore, we tested whether miR-203 transfection at DM4 could influence the fusion index of myoblasts at DM7. After miR-203 transfection, the myotubes were observed to be shorter and incomplete compared with those in the control myoblasts, The expression of miR-203 on skeletal muscle cells W Luo et al and many myoblasts were not fused to nascent myotubes (Figure 4d) . After immunofluorescence staining, we observed that the control myoblasts formed myotubes containing many nuclei, whereas the miR-203-transfected myoblasts remained mononucleated (Figure 4e ). In addition, the fusion index of the miR-203-transfected myoblasts showed that miR-203 can significantly inhibit myoblast fusion (Figure 4f) .
Furthermore, we also used anti-miR-203 and antagomir-NC (anti-NC) to test the impact of miR-203 loss-of-function during myoblast differentiation. The results showed that a significant increase in myogenin and MHC expression, as well as the fusion index, was observed, when miR-203 expression was inhibited (Figures 4g-i) . Together, we argued that miR-203 can inhibit myoblast differentiation.
c-JUN is a direct target of miR-203 in chickens. c-JUN is a positive regulator of cell proliferation, [20] [21] and c-JUN is a direct target of miR-203 in basal cell carcinoma. 35 Here, we studied the involvement of c-JUN in the inhibition of miR-203 during myoblast proliferation. c-JUN mRNA and protein level were upregulated from E10 to 1day in chicken skeletal (Figure 5f ). Furthermore, when the predicted miR-203 seed region in the 3'-UTR was mutated, the mutant reporter no longer responded to miR-203 (Figure 5f ). These results indicated that the predicted site is a target of miR-203 and is responsible for miR-203 targeting of the c-JUN 3'-UTR. Because the inhibition of cell proliferation by c-JUN is p53 dependent, 21 we also detected the expression of p53 and p21 in miR-203 overexpression and loss-of-function myoblasts and control myoblasts. Both p53 and p21 expressions were significantly downregulated or upregulated with miR-203 overexpression or loss-of-function, respectively (Figures 5g and h) . Therefore, we argued that c-JUN is a direct target of miR-203 in chickens. File 8) . Therefore, we argued that there may be another target of miR-203 that functions in myogenic differentiation. Using TargetScan Release 6.2, we found that MEF2C is the most attractive candidate because it has well-established roles in skeletal myogenesis. The protein expression of MEF2C was downregulated during E14 and E16 (Figure 7a ), and it was upregulated from proliferation to differentiation of myoblasts (Figure 7b ), demonstrating that MEF2C expression correlated with miR-203 levels in vitro and in vivo. Furthermore, the MEF2C 3'-UTR has three predicted miR-203 binding sites (Figure 7c ), and site 1 is highly conserved among vertebrates (Figure 7d ). The dual-luciferase reporter assay verified that sites 1 and 3 could be bound by miR-203, whereas the seed site mutant reporters attenuated these interactions (Figure 7e ). More importantly, miR-203 overexpression at different myoblast differentiation stages significantly inhibited the MEF2C protein level but not the MEF2C mRNA level (Figure 7f) , and the expression levels of three muscle-specific genes, MYOM1 (myomesin 1), MYOM2 (myomesin 2) and MCK (muscle creatine kinase), which are directly regulated by MEF2C, 15 were all significantly downregulated (Figure 7f ). In addition, miR-203 lossof-function increased MEF2C protein level but not mRNA level, and the three genes were all upregulated as compared with controls ( Figure 7g) .
We also used an anti-MEF2C siRNA to verify the myogenic roles of MEF2C in chicken primary myoblasts, and the siRNA and negative control duplexes were also transfected at three different stages. As shown in Figure 7h , si-MEF2C transfection significantly reduced the mRNA and protein levels of MEF2C, and the mRNA expression levels of three genes, MYOM1, MYOM2 and MCK, were all significantly reduced. However, the expression of myogenin and MHC at DM3 was the same with si-MEF2C or control transfection, whereas myogenin expression was significantly reduced at DM5. The expression levels of both myogenin and MHC were both significantly reduced at DM7 (Figure 7h ). In addition, reduced MEF2C expression also 
Discussion
In the present study, we demonstrated a transient expression pattern of miR-203 during embryonic skeletal muscle development and presented a role for miR-203 in myoblast proliferation and differentiation (Figure 8 ). miR-203 was previously described as a skin-abundant miRNA with an important role in skin differentiation, 28 and the annotation of miR-203 in miRBase shows that it is a skin-specific miRNA. 36 However, in the current study and our previous data, 33 we found that miR-203 is abundantly expressed at E14 and E16 in chicken skeletal muscle. Another study also detected miR-203 expression in chicken embryo skeletal muscle. 32 This skin-specific miRNA can also be expressed in early skeletal muscle cells, a finding that was similar to the three musclespecific miRNAs miR-1, miR-133a and miR-206 that are expressed in brown pre-and mature adipocytes. 37 Many miRNAs are not detected during early development but are expressed and functional during segmentation and differentiation. 38 The most notable myomiRs, miR-206, miR-1 and miR-133a, are all significantly upregulated during muscle differentiation. 39, 40 In our study, miR-203 is transiently upregulated at E10-E16 in chicken embryo leg muscle but is not detected after birth, indicating its potential role in muscle development.
The expression of myomiRs is often associated with phenotypic changes in skeletal muscle. 25, 41 miR-203 was shown to exhibit higher expression in E14 dwarf chickens and in layers than in E14 normal chickens and in broilers. 32 In addition, its upregulated expression in skeletal muscle correlated with slow muscle fibre formation and low muscle weight increase in the present study. The latter correlation was further validated using a series of in vitro miR-203 overexpression, loss-of-function and functional testing experiments. The expression of c-JUN and MEF2C correlated well with miR-203 expression during myoblast differentiation. In addition, subsequent miR-203 overexpression results showed that miR-203 can significantly inhibit myoblast proliferation and differentiation by repressing c-JUN and MEF2C expression. miR-203 is widely recognised as an inhibitor of proliferation in various cancer lines by repressing various target genes. 27, 30, [42] [43] [44] [45] [46] We found here that miR-203 can also inhibit myoblast proliferation by repressing c-JUN expression, an established target of miR-203 in human basal cell carcinoma. 35 In addition, p63, another target of miR-203 in skin differentiation and in RMS cells, [28] [29] [30] 47 was inhibited in miR-203-overexpressed myoblasts (Supplementary File 9) . p63 is important for cell proliferation in various tumours. 29, 47, 48 Its knockdown represses myogenic differentiation, 49 suggesting another possible regulation pathway of miR-203 in myoblast proliferation and differentiation. Collectively, miR-203 inhibits myoblast proliferation, in part, by repressing c-JUN expression.
In RMS cells, re-expression of miR-203 can induce myogenic differentiation by targeting p63 and LIFR. 30 However, p63 was found to be a positive regulator of myogenic differentiation in another research, which was a study in C2C12 cell. 49 According to our results, overexpression of miR-203 supressed myoblast differentiation, suggesting that the role of miR-203 may be different between RMS cells and myoblast. These findings were similar to the roles of miR-181s, which played a totally different role in different types of cancer cell. 50 The downregulated expression of miR-203 from myoblast proliferation to differentiation is similar to that observed for miR-155, miR-125, miR-669a and miR-669q, 2,51,52 which all act to repress skeletal muscle differentiation. MEF2C, a new target of miR-203 found in this study, is upregulated during C2C12 differentiation, 53 and its interaction with MAML1, Notch3 and the p38 MAPK pathway is required for normal myogenesis (Figure 8) . [16] [17] [18] miR-135 and miR-133 can bind to the 3'-UTR of MEF2C and MAML1, respectively, repress the expression of MEF2C and MAML1, thus inhibiting myoblast differentiation. 53 In our study, the MEF2C protein level was also upregulated during myoblast differentiation, and the overexpression of miR-203 repressed the MEF2C protein level and myoblast differentiation. Knockdown of MEF2C expression mimicked the overexpression of miR-203 by inhibiting the differentiation of myoblasts. In addition, one consequence of MEF2C activation is to increase the transcription of c-JUN in C2C12 cells and inflammatory cells, 54, 55 and the overexpression of c-JUN suppresses miR-203 expression. 56 Although our results do not verify the possibility in chicken myoblasts, they provide another source of evidence to support the regulation network of miR-203, c-JUN and MEF2C during myoblast differentiation into myotubes (Figure 8 ).
In conclusion, the embryonic expression pattern of miR-203 during skeletal muscle development in chickens is transient, and another important role of miR-203 is to repress muscle proliferation and differentiation. This repression, at least in part, is achieved by inhibiting c-JUN and MEF2C expression.
Materials and Methods Animals. The hatching eggs of dwarf and normal recessive White Rock chickens, which were both bred for nearly 10 generations, were used in this study. More than four female embryos for each group were selected for leg muscle separation, and the sex of the embryos was determined by PCR amplification using sex-specific primers. With the skin and bones removed, the weight of one of the leg muscles was immediately measured using a precision balance (Sartorius, Gottingen, Germany; sensitivity 0.1 mg), and the leg muscle was then divided into three parts. The divided parts were frozen in liquid nitrogen and stored at À 80 1C for use in DNA, RNA and protein extraction procedures. The other leg muscle sample of embryos was stored in 4% paraformaldehyde for histological analysis. Chickens were killed as necessary to ameliorate suffering.
Histology. After fixation with 4% paraformaldehyde, the leg muscle samples were embedded in paraffin, and 10-mm thick serial sections were made. The sections were then stained with H-E stain following standard protocols. Microscopic observation was performed with Carl Zeiss Primo Star microscope (Carl Zeiss, Oberkochen, Germany). Photographs were taken with a Moticam 2306 CCD imaging system (Motic Instruments lnc., CA, USA).
Cell culture DF-1 cell culture: DF-1 cells were cultured in high-glucose Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) with 10% (v/v) foetal bovine serum (Hyclone, Logan, UT, USA) and 0.2% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA).
The expression of miR-203 on skeletal muscle cells W Luo et al
Chicken primary myoblast isolation and culture: Chicken primary myoblasts were isolated from the leg muscle of E10 chickens and minced in GM consisting of RPMI-1640 medium (Gibco), 20% foetal bovine serum, 10% chicken embryo extract, 1% nonessential amino acids and 0.2% penicillin/ streptomycin. To release single cells, the suspension was shaken by repetitive vortexing and filtered to remove large debris; the cells were then collected by centrifugation at 350 g and resuspended in GM. Serial plating was performed to enrich myoblasts and eliminate fibroblasts. The differentiation of myoblasts was induced by replacing 20% foetal bovine serum with 2% horse serum (Hyclone).
RNA isolation, RT-PCR and quantitative real-time PCR. Total RNA was extracted from tissues or cells with RNAiso reagent (Takara, Otsu, Japan) and treated with DNase I (Takara). The integrity and concentration of RNA were assessed by denatured gel electrophoresis and NanoDrop 2000c (Thermo, Waltham, MA, USA). cDNA synthesis for mRNA was carried out using PrimeScript RT reagent Kit (Perfect Real Time) (Takara) for RT-PCR and qPCR. qPCR was carried out in an Bio-rad CFX96 Real-Time Detection system (Bio-rad, Hercules, CA, USA) using KAPA SYBR FAST qPCR Kit (KAPA Biosystems, Wobrun, MA, USA), and quantification was done as described. 57 For miRNA quantification, Bulge-loop miRNA qRT-PCR Primer Sets (one RT primer and a pair of qPCR (h) Primary myoblasts were transfected with anti-MEF2C siRNA or negative control duplexes at GM, DM2 and DM4, respectively, and then were incubated in differentiation medium for 3 days before qPCR and immunoblotting. (i) Microscopic images of myotubes at DM7 that were transfected with si-MEF2C or negative control duplexes at DM4. (j and k) Cells were fixed and immunostained for desmin after 3 days of si-MEF2C and negative control duplex transfection at DM4, and then were quantified for the desmin þ nuclei presented in cells with the indicated number of nuclei. All of the results are expressed as the mean ± S.E.M. of three replicates. *Po0.05; **Po0.01; ***Po0.001
The expression of miR-203 on skeletal muscle cells W Luo et al primers for each set) specific for gga-miR-203 and U6 were designed by RiboBio (RiboBio, Guangzhou, China). miRNA bulge-loop was reverse transcribed with the First-Strand cDNA Synthesis Kit (Fermentas, Burlington, CA, USA) and quantified by qPCR using KAPA SYBR FAST qPCR Kit (KAPA Biosystems) according to the indicated manufacturer's instructions.
Northern blotting and in situ hybridisation assays for miR-203. Northern blotting of miR-203 and U6 were performed with miRNA Northern Blot Assay Kit (Signosis, lnc., Sunnyvale, CA, USA) following the manufacturer's instructions. In situ hybridisation in E14 dwarf chicken leg muscle tissue was performed essentially as described by Obernosterer et al. 58 with the following modifications. The 12-mm thick cryosections were fixed in 4% PFA for 15 min at room temperature, treated for 15 min with Proteinase K, prehybridized and hybridised at 42 1C (miR-203 and scramble), and final colour development was performed with NBT/BCIP (Roche, Basel, Switzerland).
Immunoblotting and immunofluorescence. Immunoblotting was performed using standard procedures and antibodies against c-JUN (Santa Cruz Biotechnology, Santa Cruz, CA, USA), MEF2C (Santa Cruz Biotechnology), MHC (Developmental Studies Hybridoma Bank, Iowa City, Iowa, USA), myogenin (Biorbyt, Cambridge, UK) and GAPDH (Bioworld, St Louis Park, MN, USA). For immunofluorescence, primary myoblasts treated in 24-well plates were fixed in 4% formaldehyde for 20 min and then washed three times for 5 min each in PBS. The cells were then permeabilised with 0.1% Triton X-100 for 15 min and were blocked with goat serum for 1 h. After blocking, the cells were incubated with anti-desmin (Bioss, Bejing, China) overnight at 4 1C. The FITC-conjugated anti-rabbit IgG was incubated for 2 h at room temperature. The cell nuclei were visualised using DAPI staining (Beyotime, Jiangsu, China). The fusion index was calculated according to the following formula: Fusion index ¼ number of desmin þ myoblasts with more than two or five nuclei in a field/total desmin þ myoblasts number in a field.
Cell proliferation assay
Flow cytometry analysis of the cell cycle: Primary myoblast cultures in GM were collected 48 h after transfection and then fixed in 75% ethanol overnight at À 20 1C. After incubation in 50 mg/ml propidium iodide (Sigma Life Science, St. Louis, MO, USA) containing 10 mg/ml RNase A (Takara) and 0.2% (v/v) Triton X-100 (Sigma) for 30 min at 4 1C, the cells were analysed using a FACSAriaII flow cytometer (BD Biosciences, San Jose, CA, USA) and ModFit Lt 4.1 software (Verity Software House, Topsham, ME, USA).
Figure 7 (Continued)
The expression of miR-203 on skeletal muscle cells W Luo et al EdU assays: Twelve hours after transfection, primary myoblasts were exposed to 10 mM 5-ethynyl-2'-deoxyuridine (EdU; RiboBio) for 24 h at 37 1C. Next, the cells were fixed in 4% PFA for 30 min and permeabilised with 0.5% Triton X-100. Subsequently, 1 Â Apollo reaction cocktail (RiboBio) was added to the cells and incubated for 30 min, and then the cells were stained with Hoechst 33342 for 30 min for DNA content analysis. Finally, the EdU-stained cells were visualised under a fluorescence microscope (Nikon, Tokyo, Japan). The analysis of myoblast proliferation (ratio of EdU þ to all myoblasts) was performed using images of randomly selected fields obtained on the fluorescence microscope. Assays were performed three times using triplicate wells.
CCK-8 assays:
The transfected primary myoblasts were seeded at 1 Â 10 3 cells per well in a 96-well plate and cultured in GM for 4 days. Every 24 h, we added 10 ml of Cell-Counting Kit-8 (CCK-8) reagents (Dojindo Laboratories, Kumamoto, Japan) to the cells for 2 h and then measured the absorbance at 450 nm using a Model 680 Microplate Reader (Bio-Rad).
RNA oligonucleotides and transfection. The miR-203 mimics, mimic control duplexes, antagomirs of anti-miR-203 and anti-NC were purchased from RiboBio. siRNA against chicken c-JUN and MEF2C were from GenePharma (GenePharma, Suzhou, China), and a nonspecific duplex was used as the control. Transfection was performed with the Lipofectamine 2000 reagent (Invitrogen) combined with 50 nM of miRNA mimics, 200 nM of antagomir or 100 nM of siRNA and the procedure was performed according to the manufacturer's instructions.
Plasmids construction. pcDNA-3.1-c-JUN expression vector. The c-JUN coding sequence was amplified from chicken leg muscle cDNA using PCR and the following specific primers: 5 0 -CCGCTCGAGGCCACCATGGAGCCTACTTTCTAC GAG-3 0 and 5 0 -CGGGGCCCCGCTTCTACCGTCAGCTTTAC-3 0 . The PCR product was cloned into the pcDNA-3.1 vector (Promega, Madison, WI, USA) using the XhoI and ApaI restriction sites.
pmirGLO dual-luciferase miRNA target expression vector: The 3 0 -UTRs of c-JUN and MEF2C were amplified from the chicken genome and cloned into the pmirGLO dual-luciferase reporter vector (Promega) using the DraI and SalI restriction sites. Because the 3 0 -UTR of MEF2C has three predicted miR-203 binding sites that are far away from each other, we generated three pmirGLO reporter vectors of the MEF2C 3 0 -UTR. The mutant c-JUN 3'-UTR and MEF2C 3 0 -UTR plasmids were generated by changing the miR-203 binding site from ATTTCA to CGCGGC, and mutagenesis was performed by PCR amplification and DpnI digestion to remove the parental DNA.
Dual-luciferase reporter assay. DF-1 cells were co-transfected with 100 ng of the wild-type or mutant 3'-UTR dual-luciferase reporter and 50 nM of the miR-203 mimic or negative control duplexes using Lipofectamine 2000 reagent in 96-well plates. After transfection for 48 h, the activities of firefly and Renilla luciferase were analysed using a dual-luciferase reporter assay system (Promega) following the manufacturer's instructions. The luminescent signal was quantified using a Fluorescence/Multi-Detection Microplate Reader (Synergy 2, Biotek, Winooski, VT, USA) and analysed with Gene5 software (Biotek, Bad Friedichshall, Germany).
Statistical analysis. All results are presented as mean±S.E.M. based on at least three replicates for each treatment. Unpaired Student's t-test was used for P-value calculations.
Ethics standards. The experiments in this study were approved by Animal Care Committee of South China Agricultural University (Guangzhou, China) with approval number SCAU#0014, and the chickens were humanely killed as necessary to ameliorate their suffering.
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